ConductScience.org, home

Paper35722356

Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.

Peng D and 7 others. Ann Transl Med, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report. Papers, record 35722356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35722356

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.
PubMed
Journal
Ann Transl Med
PubMed
Year
2022
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2022-07-16
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peng DDanyang
2Zhang FFan
3Lv PPin
4Chen YYinyin
5Yang JJianxu
6Zhu WWenliang
7Zhu SShichao
8Shao HHuanzhang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123179561Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis.J Antimicrob Chemother2013https://conductscience.org/library/papers/23179561PubMed
224749079Global survey of polymyxin use: A call for international guidelines.J Glob Antimicrob Resist2013https://conductscience.org/library/papers/24749079PubMed
330582435Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients.Expert Opin Drug Metab Toxicol2019https://conductscience.org/library/papers/30582435PubMed
427474468Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.Int J Antimicrob Agents2016https://conductscience.org/library/papers/27474468PubMed
520028824Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20028824PubMed
629334366Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy.Chemotherapy2018https://conductscience.org/library/papers/29334366PubMed
732383061Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper.Intensive Care Med2020https://conductscience.org/library/papers/32383061PubMed
832547394Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.Front Pharmacol2020https://conductscience.org/library/papers/32547394PubMed
927553752Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.Clin Ther2016https://conductscience.org/library/papers/27553752PubMed
1028275006Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Clin Microbiol Rev2017https://conductscience.org/library/papers/28275006PubMed
1122615285Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22615285PubMed
1231767718Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).Antimicrob Agents Chemother2020https://conductscience.org/library/papers/31767718PubMed
1331637180Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration.J Transl Int Med2019https://conductscience.org/library/papers/31637180PubMed
1433832018[Multi-disciplinary expert consensus on the optimal clinical use of the polymyxins in China].Zhonghua Jie He He Hu Xi Za Zhi2021https://conductscience.org/library/papers/33832018PubMed
1531764007Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter?Curr Opin Anaesthesiol2020https://conductscience.org/library/papers/31764007PubMed
1628628170Recent advances and perspectives in the design and development of polymyxins.Nat Prod Rep2017https://conductscience.org/library/papers/28628170PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40246790A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations.Clin Pharmacokinet2025https://conductscience.org/library/papers/40246790PubMed
39367501A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation.Crit Care2024https://conductscience.org/library/papers/39367501PubMed
38974043Polymyxins: recent advances and challenges.Front Pharmacol2024https://conductscience.org/library/papers/38974043PubMed
37518089
Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial - a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial.
BMJ Open2023https://conductscience.org/library/papers/37518089PubMed
36978342Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.Antibiotics (Basel)2023https://conductscience.org/library/papers/36978342PubMed
36978303Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review.Antibiotics (Basel)2023https://conductscience.org/library/papers/36978303PubMed
36643845Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections.Front Med (Lausanne)2022https://conductscience.org/library/papers/36643845PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35722356

GET https://conductscience.org/api/papers/v1/35722356/authors